✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Regeneron Pharmaceuticals Inc

Common Name
Regeneron Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
15,410
Ticker
REGN
Exchange
NASDAQ/NGS
Description
Regeneron Pharmaceuticals discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company operates across multiple therapeutic areas, with flagship...
Data not available

Regeneron Pharmaceuticals is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Regeneron Pharmaceuticals is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.